Biotech Co. Defends Antitrust Counterclaims Against Rival

By Jared Foretek

Biotech company Zymo Research Corp. is defending its claims that German diagnostic competitor Qiagen GmbH's infringement suit is nothing more than an attempt to discredit a competitor, saying Zymo offered to prove it wasn't ripping off Qiagen's tech, only to have Qiagen bury "its head in the sand" and file suit.

 Response attached | Read full article » | Save to favorites »